View in EDS HTML Full Text PDF Full Text

Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma.

Saved in:
Bibliographic Details
Title: Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma.
Authors: Abou-Alfa GK; Weill Medical College at Cornell University, New York, New York, USA.; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Mayer R; Dana-Farber Cancer Institute, Harvard University, Boston, Massachusetts, USA., Venook AP; University of California San Francisco, San Francisco, California, USA., O'Neill AF; Dana-Farber Cancer Institute, Harvard University, Boston, Massachusetts, USA., Beg MS; UT Southwestern Medical Center, Dallas, Texas, USA., LaQuaglia M; Weill Medical College at Cornell University, New York, New York, USA.; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Kingham PT; Weill Medical College at Cornell University, New York, New York, USA.; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Kobos R; Weill Medical College at Cornell University, New York, New York, USA.; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Basturk O; Weill Medical College at Cornell University, New York, New York, USA.; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Brennan C; Weill Medical College at Cornell University, New York, New York, USA.; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Yopp A; UT Southwestern Medical Center, Dallas, Texas, USA., Harding JJ; Weill Medical College at Cornell University, New York, New York, USA.; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Leong S; University of Colorado Cancer Center, Aurora, Colorado, USA., Crown J; St Vincent's Private Hospital, Dublin, Ireland., Hoti E; St Vincent's Private Hospital, Dublin, Ireland., Leonard G; Galway University Hospital, Galway, Ireland., Ly M; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Bradley M; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Valentino E; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Markowitz D; CASI Pharmaceuticals, Inc., Rockville, Maryland, USA., Zukiwski A; CASI Pharmaceuticals, Inc., Rockville, Maryland, USA., Ren K; CASI Pharmaceuticals, Inc., Rockville, Maryland, USA., Gordan JD; University of California San Francisco, San Francisco, California, USA.
Source: The oncologist [Oncologist] 2020 Dec; Vol. 25 (12), pp. e1837-e1845. Date of Electronic Publication: 2020 Mar 10.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32154962
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Abou-Alfa+GK%22">Abou-Alfa GK</searchLink>; Weill Medical College at Cornell University, New York, New York, USA.; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Mayer+R%22">Mayer R</searchLink>; Dana-Farber Cancer Institute, Harvard University, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Venook+AP%22">Venook AP</searchLink>; University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22O'Neill+AF%22">O'Neill AF</searchLink>; Dana-Farber Cancer Institute, Harvard University, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Beg+MS%22">Beg MS</searchLink>; UT Southwestern Medical Center, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22LaQuaglia+M%22">LaQuaglia M</searchLink>; Weill Medical College at Cornell University, New York, New York, USA.; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Kingham+PT%22">Kingham PT</searchLink>; Weill Medical College at Cornell University, New York, New York, USA.; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Kobos+R%22">Kobos R</searchLink>; Weill Medical College at Cornell University, New York, New York, USA.; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Basturk+O%22">Basturk O</searchLink>; Weill Medical College at Cornell University, New York, New York, USA.; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Brennan+C%22">Brennan C</searchLink>; Weill Medical College at Cornell University, New York, New York, USA.; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Yopp+A%22">Yopp A</searchLink>; UT Southwestern Medical Center, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Harding+JJ%22">Harding JJ</searchLink>; Weill Medical College at Cornell University, New York, New York, USA.; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Leong+S%22">Leong S</searchLink>; University of Colorado Cancer Center, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Crown+J%22">Crown J</searchLink>; St Vincent's Private Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Hoti+E%22">Hoti E</searchLink>; St Vincent's Private Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Leonard+G%22">Leonard G</searchLink>; Galway University Hospital, Galway, Ireland.<br /><searchLink fieldCode="AU" term="%22Ly+M%22">Ly M</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Bradley+M%22">Bradley M</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Valentino+E%22">Valentino E</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Markowitz+D%22">Markowitz D</searchLink>; CASI Pharmaceuticals, Inc., Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Zukiwski+A%22">Zukiwski A</searchLink>; CASI Pharmaceuticals, Inc., Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Ren+K%22">Ren K</searchLink>; CASI Pharmaceuticals, Inc., Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Gordan+JD%22">Gordan JD</searchLink>; University of California San Francisco, San Francisco, California, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229607837%22">The oncologist</searchLink> [Oncologist] 2020 Dec; Vol. 25 (12), pp. e1837-e1845. <i>Date of Electronic Publication: </i>2020 Mar 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9607837 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-490X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210837159%22">10837159 </searchLink><i>NLM ISO Abbreviation: </i>Oncologist <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32154962
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1634/theoncologist.2020-0093
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1837
    Titles:
      – TitleFull: Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Abou-Alfa GK
      – PersonEntity:
          Name:
            NameFull: Mayer R
      – PersonEntity:
          Name:
            NameFull: Venook AP
      – PersonEntity:
          Name:
            NameFull: O'Neill AF
      – PersonEntity:
          Name:
            NameFull: Beg MS
      – PersonEntity:
          Name:
            NameFull: LaQuaglia M
      – PersonEntity:
          Name:
            NameFull: Kingham PT
      – PersonEntity:
          Name:
            NameFull: Kobos R
      – PersonEntity:
          Name:
            NameFull: Basturk O
      – PersonEntity:
          Name:
            NameFull: Brennan C
      – PersonEntity:
          Name:
            NameFull: Yopp A
      – PersonEntity:
          Name:
            NameFull: Harding JJ
      – PersonEntity:
          Name:
            NameFull: Leong S
      – PersonEntity:
          Name:
            NameFull: Crown J
      – PersonEntity:
          Name:
            NameFull: Hoti E
      – PersonEntity:
          Name:
            NameFull: Leonard G
      – PersonEntity:
          Name:
            NameFull: Ly M
      – PersonEntity:
          Name:
            NameFull: Bradley M
      – PersonEntity:
          Name:
            NameFull: Valentino E
      – PersonEntity:
          Name:
            NameFull: Markowitz D
      – PersonEntity:
          Name:
            NameFull: Zukiwski A
      – PersonEntity:
          Name:
            NameFull: Ren K
      – PersonEntity:
          Name:
            NameFull: Gordan JD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2020 Dec
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1549-490X
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: The oncologist
              Type: main
ResultId 1